Deferoxamine (CAS 70-51-9)
Alternate Names:
deferoxamine Desferrioxamine B DESFERRIOXAMINE Deferoxamin DFO
CAS Number:
70-51-9
Molecular Weight:
560.68
Molecular Formula:
C25H48N6O8
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Deferoxamine (CAS 70-51-9) References
- Deferoxamine pharmacokinetics. | Porter, JB. 2001. Semin Hematol. 38: 63-8. PMID: 11206963
- Deferoxamine (desferrioxamine). New toxicities for an old drug. | Bentur, Y., et al. 1991. Drug Saf. 6: 37-46. PMID: 2029352
- Deferoxamine therapy for intracerebral hemorrhage: A systematic review. | Zeng, L., et al. 2018. PLoS One. 13: e0193615. PMID: 29566000
- Deferoxamine to Minimize Fibrosis During Radiation Therapy. | Tevlin, R., et al. 2022. Adv Wound Care (New Rochelle). 11: 548-559. PMID: 34074152
- Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells. | Ghislanzoni, S., et al. 2023. Int J Biochem Cell Biol. 159: 106419. PMID: 37086817
- Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. | Jia, H., et al. 2023. Brain Res. 1812: 148383. PMID: 37149247
- Deferoxamine Interference in Fibro-inflammation: Additional Action in Control of Obese Adipose Tissue Dysfunction. | Gotardo, EMF., et al. 2023. Curr Drug Targets. 24: 688-696. PMID: 37278033
- Deferoxamine attenuates visual impairment in retinal ischemia‒reperfusion via inhibiting ferroptosis. | Wang, X., et al. 2023. Sci Rep. 13: 20145. PMID: 37978208
- Application of Deferoxamine in Tissue Regeneration Attributed to Promoted Angiogenesis. | Shen, H., et al. 2024. Molecules. 29: PMID: 38731540
- Risks of parenteral deferoxamine for acute iron poisoning. | Howland, MA. 1996. J Toxicol Clin Toxicol. 34: 491-7. PMID: 8800186
Inhibitor of:
ABCE1, ALKBH5, Aminolevulinate Dehydratase (ALAD) inhibitors, ASPHD2, BOLA2B, Calgranulin B, CD71, CHDH, CRS1C-2, CYB5D1, CYBRD1, EG434727, EG434729, EG436003, Ferrochelatase, FIH-1, FLVCR2, Hemoglobin α1, Hemoglobin α2, Hepcidin, Hephaestin, HRCT1, HscB, IRP-1, ISCA1/1L, ISCA2, IscU1, IscU2, LEPREL1, LEPREL4, melanotransferrin, Metallothionein 1A, NFU1, NRAMP2, Obox6, OGFOD3, p22HBP, Protein tyrosine phosphatase receptor (PTPR), PTPκ, PUS10, RGMc, SLC48A1, STEAP, TFR2, TMEM164, TYW1, UROS, VAT1L, VHL, Yfh1, ZIM2, ZIP10, ZIP4, ZNF618, ZNF74, and ZnT-7.Activator of:
ABCB7, Arn1, Baculovirus gp64, CA IX, CPOX, Dengue Virus 2, DPRP1, E330017A01Rik, ERIS, Ero1-Lα, FAM96A, FBL5, ferritin, ferritin light chain, Ferroportin-1, FRP-1, FRP1, Hbb-bh1, Hbb-y, HCCS, Hemoglobin α, Hemopexin, HFE, HID, HIF-1 alpha, HIGD1B, HIGD1C, HILPDA, HPR, IdnK, IRP-2, MIOS, mitochondrial ferritin, MMS19, NDRG3, NDUFA11, NDUFB7, ORP150, P4H-TM, PGLS, PHD1, PIGF, PIGF-2, PlGF2, RNA pol σ fecI, RV3134 Dormancy Regulon, SIAH-2, SLC39A12, TLL2, TMEM14A, TMEM14C, transferrin, Transferrinm Solution, UROD, VEGF-D, YadA, and ZnT-4.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Deferoxamine, 5 mg | sc-507390 | 5 mg | $255.00 |